INVARIANT LLC

Lobbying for MICRO MEDICAL SOLUTIONS · Medical technology company developing devices and therapies for treating vascular diseases

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate · $50,000.00 income · posted Jul 20, 2026

Lobbying activity 1

Health Issues

Educate policymakers about new technologies for treating patients with advanced vascular disease.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.